Viral strategies of immune evasion

Science

Volumn 280, Issue 5361, 1998, Pages 248-253

  Ploegh, Hidde L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTATION; ARTICLE; CYTOMEGALOVIRUS; ENDOCYTOSIS; EPSTEIN BARR VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOREGULATION; INTERNALIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; CYTOKINES; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KILLER CELLS, NATURAL; T-LYMPHOCYTES, CYTOTOXIC; VIRUS DISEASES; VIRUSES;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; VERTEBRATA;

EID: 0032503029     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.280.5361.248     Document Type: Article

References (55)

1. H. Hengel and U. H. Koszinowski, Curr. Opin. Immunol. 9, 470 (1997).
2. M. K. Spriggs, Annu. Rev. Immunol. 14, 101 (1996).
3. N. J. Davis-Poynter and H. E. Farrell, Semin. Virol., in press.
4. G. L. Smith, J. A. Symons, A. Khanna, A. Vanderplasschen, A. Alcami, Immunol. Rev. 159, 137 (1997).
5. G. McFadden, K. Graham, M. Barry, Transplant. Proc. 28, 2085 (1996).
6. K. L. Rock, Immunol. Today 17, 131 (1996).
7. R. Rotem-Yehudar, M. Groettrup, A. Soza, P. M. Kloetzel, R. Ehrlich, J. Exp. Med. 183, 499 (1996).
8. M. J. Gilbert, S. R. Riddell, B. Plachter, P. D. Greenberg, Nature 383, 720 (1996).
9. J. Levitskaya, A. Sharipo, A. Leonchiks, A. Ciechanover, M. G. Masucci, Proc. Natl. Acad. Sci. U.S.A. 94, 12616 (1997).
10. F. Ossendorp et al., Immunity 5, 115 (1996).
11. A. Bertoletti et al., Nature 369, 407 (1994).
12. P. Klenerman et al., ibid., p. 403.
13. I. A. York et al., Cell 77, 525 (1994); A. Hill et al., Nature 375, 411 (1995); R. Tomazin et al., EMBO J. 15, 3256 (1996); K. Ahn et al., ibid., p. 3247.
14. I. A. York et al., Cell 77, 525 (1994); A. Hill et al., Nature 375, 411 (1995); R. Tomazin et al., EMBO J. 15, 3256 (1996); K. Ahn et al., ibid., p. 3247.
15. I. A. York et al., Cell 77, 525 (1994); A. Hill et al., Nature 375, 411 (1995); R. Tomazin et al., EMBO J. 15, 3256 (1996); K. Ahn et al., ibid., p. 3247.
16. I. A. York et al., Cell 77, 525 (1994); A. Hill et al., Nature 375, 411 (1995); R. Tomazin et al., EMBO J. 15, 3256 (1996); K. Ahn et al., ibid., p. 3247.
17. H. Hengel et al., Immunity 6, 623 (1997); K. Ahn et al., ibid., p. 613.
18. H. Hengel et al., Immunity 6, 623 (1997); K. Ahn et al., ibid., p. 613.
19. S. Paabo et al., Adv. Cancer Res. 52, 151 (1989).
20. K. Ahn et al., Proc. Natl. Acad. Sci. U.S.A. 93, 10990 (1996); T. R. Jones et al., ibid., p. 11327.
21. K. Ahn et al., Proc. Natl. Acad. Sci. U.S.A. 93, 10990 (1996); T. R. Jones et al., ibid., p. 11327.
22. H. Ziegler et al., Immunity 6, 57 (1997).
23. E. J. Wiertz et al., Nature 384, 432 (1996); E. J. Wiertz et al., Cell 84, 769 (1996).
24. E. J. Wiertz et al., Nature 384, 432 (1996); E. J. Wiertz et al., Cell 84, 769 (1996).
25. R. R. Kopito, Cell 88, 427 (1997).
26. T. Kerkau et al., J. Exp. Med. 185, 1295 (1997).
27. M. F. Kleijnen et al., EMBO J. 16, 685 (1997).
28. C. Aiken, J. Konner, N. R. Landau, M. E. Lenburg, D. Trono, Cell 76, 853 (1994).
29. O. Schwartz, V. Marechal, S. Le Gall, F. Lemonnier, J. M. Heard, Nature Med. 2, 338 (1996).
30. T. Kirchhausen, J. S. Bonifacino, H. Riezman, Curr. Opin. Cell Biol. 9, 488 (1997).
31. M. E. Greenbsrg et al., EMBO J. 16, 6964 (1997).
32. K. L. Collins, B. K. Chen, S. Kalams, B. D. Walker, D. Baltimore, Nature, in press.
33. K. Karre and R. M. Welsh, ibid. 386, 446 (1997); K. Karre, Immunol. Rev. 155, 5 (1997).
34. K. Karre and R. M. Welsh, ibid. 386, 446 (1997); K. Karre, Immunol. Rev. 155, 5 (1997).
35. H. E. Farrell et al., Nature 386, 510 (1997).
36. H. T. Reyburn et al., ibid., p. 514.
37. D. Cosman et al., Immunity 7, 273 (1997).
38. P. R. Wolf and H. L. Ploegh, Annu. Rev. Cell Dev. Biol. 11, 267 (1995).
39. D. M. Miller et al., J. Exp. Med. 187, 675 (1998).
40. D. D. Sedmak et al., Am. J. Pathol. 144, 683 (1994).
41. B. Koppelman, J. J. Neefjes, J. E. de Vries, R. de Waal Malefyt, Immunity 7, 861 (1997).
42. X. Tong, W. Boll, T. Kirchhausen, P. M. Howley, J. Virol. 72, 476 (1998).
43. E. C. Dell'Angelica et al., EMBO J. 16, 917 (1997).
44. C. R. Cowles, G. Odorizzi, G. S. Payne, S. D. Emr, Cell 91, 109 (1997).
45. T. Andresson, J. Sparkowski, D. J. Goldstein, R. Schlegel, J. Biol. Chem. 270, 6830 (1995).
46. M. Molinari et al., J. Exp. Med. 187, 135 (1998).
47. A. Zdanov, C. Schalk-Hihi, S. Menon, K. W. Moore, A. Wlodawer, J. Mol. Biol. 268, 460 (1997).
48. S. V. Kotenko et al., EMBO J. 16, 5894 (1997).
49. R. Zeidler et al., Blood 90, 2390 (1997).
50. L. D. Strockbine et al., J. Virol., in press.
51. C. A. Smith et al., Virology 236, 316 (1997).
52. C. L. Karp et al., Science 273, 228 (1996).
53. M. Irmler et al., Nature 388, 190 (1997).
54. J. L. Shisler, T. G. Senkevich, M. J. Berry, B. Moss, Science 279, 102 (1998).
55. I thank M. K. Spriggs for essential contributions to the manuscript, A. Abbas and A. C. Bannister for helpful comments on the manuscript, and J. Huppa for preparation of the figures.